The trajectory of copyright's flagship drug presents a nuanced case for investors in the medicinal sector. While initially a phenomenal success, generating huge profits, the patent lapse and the subsequent entry of https://adult184637.bloggip.com/42213772/sildenafil-and-pharma-a-hazardous-bet